| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.081 | 0.1 |